The U.S. owns the lead in the critical categories of scientific quality and commercial know-how. However, Chinese development is faster, bigger and cheaper—and gaining on us. Which nation will ultimately prevail?
Any lingering fears about patients using online portals to get bonus medical attention for free should be largely quieted, albeit not completely silenced, by a new study conducted at New York University.
Medaxiom CEO Jerry Blackwell, MD, MBA, FACC, discusses investor's interest in buying cardiology practices, noting that PE ownership remains relatively low.
Chair of the department of cardiothoracic surgery at Stanford University School of Medicine, and associate director of the Stanford Cardiovascular Institute, is the new 2026-27 president of the AATS.
More than 15 years after the National Academy of Medicine summoned a blue-ribbon panel to “reimagine” the Department of Health and Human Services for the 21st century, the cabinet-level operation has yet to make good on the experts’ overarching directive.
There is a belief among some clinicians that it is too easy for companies to gain CE mark approval for their medical devices. However, a new proposal from the European Society of Cardiology and other groups could help change that.
The FDA is warning the public that certain Medline surgical kits may contain catheters that have been linked to 41 customer complaints and three serious injuries.
The Urology Management Alliance is teaming with IR Centers, a platform company dedicated to offering minimally invasive procedures in outpatient settings.
The U.S. owns the lead in the critical categories of scientific quality and commercial know-how. However, Chinese development is faster, bigger and cheaper—and gaining on us. Which nation will ultimately prevail?
Any lingering fears about patients using online portals to get bonus medical attention for free should be largely quieted, albeit not completely silenced, by a new study conducted at New York University.
Medaxiom CEO Jerry Blackwell, MD, MBA, FACC, discusses investor's interest in buying cardiology practices, noting that PE ownership remains relatively low.
